Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: Mol Pharm. 2018 Mar 16;15(9):3723–3728. doi: 10.1021/acs.molpharmaceut.8b00074

Figure 6.

Figure 6

Targeting of alloimmune B cells using hRBC-NPs. Leukocytes were isolated from mice sensitized to hRBC membrane or from naïve mice. Subsequently, the cells were incubated with DiD-labeled hRBC-NPs and analyzed by flow cytometry; a FITC-conjugated CD19 antibody was used to identify the B cell population during analysis (n = 5 for naïve, 15 for sensitized; mean ± SD). ****p < 0.0001; Student’s t-test.